Several other invasive malignancies such as sarcoma, lung, and prostate cancers, showed enrichment of CARF expression at Oncomine, suggesting clinical relevance of CARF upregulation with metastatic cancers. This evidence concerns the gene CARF and Familial prostate cancer.